Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.25
-0.19 (-3.49%)
At close: Aug 15, 2025, 2:03 PM

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics reported an annual revenue of $7.69M, reflecting a -2.36% growth. For the quarter ending March 31, 2025, Bolt Biotherapeutics generated $1.22M in revenue.
Revenue (ttm)
7.69M
Revenue Growth
-2.36%
Price / Sales Ratio
53.13
Revenue / Employee
147.88K
Employees
52
Market Cap
10.06M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.